<DOC>
	<DOCNO>NCT03011632</DOCNO>
	<brief_summary>The project intend realise two phase . In first stage , case control study perform . In second phase , double-blind , placebo control study conduct . In first phase 3 group child compare : ) group child suffer chronic rhinosinusitis ( CRS ) ( fulfil European Position Paper Rhinosinusitis Nasal Polyps ( EPOS ) criterion ) asthma ( fulfil Asthma Predictive Index ( API ) criterion ) ( CRS+/asthma+ , n=90 ) , ii ) group child suffer CRS ( fulfil EPOS criterion ) without asthma symptom ( negative API criterion ) ( CRS+/asthma- , n=30 ) iii ) group child without symptom CRS ( negative EPOS criterion ) without asthma symptom ( negative API criterion ) ( CRS-/asthma- , n=30 ) . In second phase effect intranasal glucocorticosteroids assess . The following research method use : CRS-symptom score questionnaire ( SN-5 ) Childhood Asthma Control Test ( cACT ) questionnaires , skin prick test , spirometry , measurement nitric oxide NO exhale breath ( FeNO ) , taste perception test , eosinophil morphology assessment , ratio : glucose concentration nasal secretion/serum glucose level , concentration specific immunoglobulin ( Ig ) E , total immunoglobulin G ( IgG ) immunoglobulin A ( IgA ) , proportion innate lymphoid cell ( ILC ) regulatory lymphocyte cell peripheral blood . Endoscopic examination upper airways perform sample mucosa take . The mucosal examination follow : ) polymerase chain reaction ( PCR ) examination detection presence viral bacterial genetic material , ii ) measurement expression various messenger ribonucleic acid ( mRNA ) , iii ) measurement expression mRNA Epithelial-Mesenchymal Transition ( EMT ) gene iv ) percentage ILCs .</brief_summary>
	<brief_title>Response Airway Sinusitis Asthma</brief_title>
	<detailed_description>Persistence CRS asthma require multiple interconnected feedback feed-forward circuit ILCs epithelial cell . It seem type 2 ILCs ( ILC2 ) important accelerator type II immune response prepare cytokine microenvironment Th2 cell chronic activation . What decide ILC2 accumulation - urgent question . The aim propose project examine role innate immune response airways child suffer chronic rhinosinusitis asthma . The project intend realise two phase . In first stage , case control study perform . In second phase , double-blind , placebo control study conduct . In first phase 3 group child compare : ) group child suffer CRS ( fulfil EPOS criterion ) asthma ( fulfil API criterion ) ( CRS+/asthma+ , n=90 ) , ii ) group child suffer CRS ( fulfil EPOS criterion ) without asthma symptom ( negative API criterion ) ( CRS+/asthma- , n=30 ) iii ) group child without symptom CRS ( negative EPOS criterion ) without asthma symptom ( negative API criterion ) ( CRS-/asthma- , n=30 ) . In second phase effect intranasal glucocorticosteroids assess . The following research method use : SN-5 cACT questionnaire , skin prick test , spirometry , measurement NO exhale breath , taste perception test , eosinophil morphology assessment , ratio : glucose concentration nasal secretion/serum glucose level , concentration specific immunoglobulin E , total IgG IgA , proportion ILC2 cell regulatory cell peripheral blood . Endoscopic examination upper airways perform sample mucosa take . The mucosal examination follow : ) PCR examination detection presence viral bacterial genetic material , ii ) measurement expression various mRNA type , iii ) measurement expression mRNA Epithelial-Mesenchymal Transition ( EMT ) gene iv ) percentage ILC 1 , 2 3 cell regulatory cell .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>group child ( n=90 ) suffer CRS ( fulfil EPOS criterion , European Position Paper Rhinosinusitis Nasal Polyps ) asthma ( fulfil API criterion , Asthma Predictive Index ) , include 30person subgroup diagnose clinically significant IgEdependent hypersensitivity ( accordance symptom current exposure sensitize allergen ) , group child ( n=30 ) suffer CRS ( fulfil EPOS criterion ) without asthma symptom ( negative API criterion ) , include 15person subgroup diagnose clinically significant IgEdependent hypersensitivity ( accordance symptom current exposure sensitize allergen ) , group child ( n=30 ) without symptom CRS ( negative EPOS criterion ) without asthma symptom ( negative API criterion ) . food allergy symptom affect respiratory tract contraindication nasal endoscopy contraindication nasal mucosa biopsy hypertrophy third tonsil exceed 60 % nasopharynx ( criterion obstruction indication adenoidectomy ) . In patient , anatomical nasal obstruction may single cause chronic inflammation airway , hence verification hypotheses impossible confirmed immunodeficiency exacerbation asthma require systemic administration glucocorticosteroids obesity , exposure tobacco smoke chronic illness clinical condition , opinion researcher may influence evaluation course study .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>